Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare

Journal of Cancer Epidemiology - United States
doi 10.1155/2012/978391
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Subgroups of High-Cost Medicare Advantage Patients: An Observational Study

Journal of General Internal Medicine
Internal Medicine
2018English

An International Comparison of the Efficacy, Cost and Myelotoxicity of First-Line Therapy for Advanced Follicular Non-Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine

Cancer Management and Research
Oncology
2015English

Cost-Effectiveness of First-Line Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer Unsuitable for Chemotherapy

BMJ Open
Medicine
2015English

Characteristics and Outcomes of Patients With Relapsed Follicular Lymphoma Following Retreatment With Second-Line Rituximab-Containing Chemotherapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Bevacizumab in First-Line Treatment of Elderly Patients With Metastatic Colorectal Cancer: German Community-Based Observational Cohort Study Results

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Cost-Effectiveness of Adding Rituximab to Splenectomy and Romiplostim for Treating Steroid-Resistant Idiopathic Thrombocytopenic Purpura in Adults

BMC Health Services Research
Health Policy
2015English

M7‐FLIPI Is Not Prognostic in Follicular Lymphoma Patients With First‐line Rituximab Chemo‐free Therapy

British Journal of Haematology
Hematology
2019English

Rituximab as First Choice for Patients With Refractory Rheumatoid Arthritis: Cost-Effectiveness Analysis in Iran Based on a Systematic Review and Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy